Introduction Depressive symptoms are experienced by up to 50% of individuals diagnosed
with Multiple Sclerosis (MS). Furthermore, depressive symptoms are sometimes …

Background To determine and compare comorbidity levels in the multiple sclerosis (MS)
population in Poland using a matched cohort from the general population. Methods We …

Background The exact cause of Multiple Sclerosis (MS) is unclear. Since its definition in the
late 19th century, researchers have repeatedly suggested a connection between the …

Chronic diseases are the primary cause of disability, morbidity, and death in Western
developed countries. Many of these diseases are related to environmental influences …

Objective To compare and characterize major depressive disorder (MDD) subtypes (ie, pure
atypical, pure melancholic and mixed atypical-melancholic) and depression symptoms in …

Background Comorbidity decreases the likelihood of initiating disease-modifying therapy
(DMT) for multiple sclerosis (MS). Our objective was to characterize the relationship between …

Abstract Background People with MS (pwMS) have higher prevalence of comorbidities at
disease onset and face increased risk of developing cardiovascular disorders. Stroke is of …

Objective: To investigate the frequency of Comorbid Fibromyalgia Syndrome and its effects
on quality of life and activities of daily living without any known psychiatric problem …

Objective We tested for the presence of differential item functioning (DIF) in commonly used
measures of depressive symptoms, in people with multiple sclerosis (MS) versus people …

Multiple sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous
system of a chronic nature, most often with periods of exacerbation and remission, mainly …